Table 1.
Comparisons | New onset stage 3 or more CKD | New onset albuminuria | Kidney failure | New onset rapid decline of eGFR (⩾3 ml/min per 1.73 m2 per year) |
---|---|---|---|---|
Highest versus lowest sUA tertile/quartile/quintile | sUA quartiles: OR/HR 2.13, 95% CI 1.74–2.61, p < 0.00001, I2 of 80%*§; very low certainty evidence (n = 20) | sUA tertiles: OR/HR 1.94, 95% CI 1.34–2.79, p = 0.0004, I2 of 81%; multivariable adjusted¶; very low certainty evidence (n = 8) | sUA tertiles: HR 1.53, 95% CI 1.18–1.99, p = 0.001, I2 of 79%; multivariable adjusted§; very low certainty evidence (n = 9) | sUA quintiles: OR 1.38, 95% CI 1.20– 1.59, p < 0.00001, I2 of 0%; multivariable adjusted§; low certainty evidence (n = 4) |
Hyperuricemia versus normouricemia | OR/HR 1.78, 95% CI 1.50– 2.13, p < 0.00001, I2 of 38%; multivariable adjusted†¶; very low certainty evidence (n = 6) | OR 3.05, 95% CI 1.06–8.77, p = 0.04, I2 of 83%; multivariable adjusted¶; low certainty evidence (n = 2) | HR 2.08, 95% CI 1.23–3.51, p = 006, I2 of 91%; multivariable adjusted§; low certainty evidence (n = 6) | No data |
Every 1 mg/dl increase of sUA | OR/HR 1.15, 95% CI 1.09–1.22, p < 0.00001, I2 of 68%; multivariable adjusted§; very low certainty evidence (n = 11) | OR/HR 1.30, 95% CI 1.10–1.53, p = 0.002, I2 of 63%‡§; very low certainty evidence (n = 5) | HR 1.07, 95% CI 1.01–1.12, p = 0.01, I2 of 81%; multivariable adjusted§; very low certainty evidence (n = 10) | OR 1.22, 95% CI 1.14–1.30, p < 0.00001, I2 of 36%; multivariable adjusted§; very low certainty evidence (n = 5) |
Separate analyses for OR and HR were significant for CKD stage 3 or higher.
Corresponding separate analyses for OR and HR were significant for CKD.
Separate analyses of OR and HR, which were significant for albuminuria.
Regardless of baseline kidney function.
Normal baseline kidney function.
CI, confidence interval; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; HR, hazard ratio; OR, odds ratio; sUA, serum urate.